Andrew Guggenhime - Sep 5, 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
President and CFO
Signature
Andrew Guggenhime, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Sep 5, 2023
Transactions value $
-$181,968
Form type
4
Date filed
9/6/2023, 05:34 PM
Previous filing
Mar 3, 2023
Next filing
Oct 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability -$182K -3.57K -4.3% $51.00 79.5K Sep 5, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F2 Includes 1,040 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2023.